Jason L Freedman, MD, MSCE
Assistant Professor of Clinical Pediatrics (Oncology)
Attending Physician, Division of Oncology, Children’s Hospital of Philadelphia
Director, Oncology/BMT Hospitalist Program, Division of Oncology, Children's Hospital of Philadelphia
Medical Director, Oncology/BMT Inpatient Unit, Division of Oncology, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Oncology, HUB 3523
3501 Civic Center Boulevard
Philadelphia, PA 19104
Division of Oncology, HUB 3523
3501 Civic Center Boulevard
Philadelphia, PA 19104
Email:
freedmanj@chop.edu
freedmanj@chop.edu
Publications
Education:
BS
Cornell University, 2002.
MD
State University of New York Upstate Medical University, 2006.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2013.
Permanent linkBS
Cornell University, 2002.
MD
State University of New York Upstate Medical University, 2006.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2013.
Description of Clinical Expertise
Pediatric Stem Cell TransplantationPediatric Oncology
Pediatric Supportive Care
Description of Other Expertise
Medical Director & Inpatient AdministrationHospitalist Medicine in Pediatric Hematology/Oncology
Quality Improvement in Pediatric Oncology
Description of Research Expertise
Clinical Trials in Pediatric Supportive CareEpidemiologic studies in Supportive Care
Selected Publications
Myers R, Mumanachit S, Maude SL, Dinofia AM, Freedman JL, Bunin N, Wray L, Barz Leahy A, Olson TS, Grupp S, Seif AE, Elgarten CW : Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia (Poster Presentation). American Society of Hematology (ASH) Annual Meeting, San Diego, California December 2023.Jodele S, Dandoy CE, Aguayo-Hiraldo P, Lane A, Teusink-Cross A, Sabulski A, Mizuno K, Laskin BL, Freedman JL, Davies SM: Prospective Multi-Institutional Study of Eculizumab to Treat High-Risk Stem Cell Transplant Associated TMA. Blood Nov 2023 Notes: doi: 10.1182/blood.2023022526. [Epub ahead of print]
Schuster JE, Hamdan L, Dulek DE, Kitko CL, Batarseh E, Haddadin Z, Stewart LS, Stahl A, Potter M, Rahman H, Kalams SA, Bocchini CE, Moulton EA, Coffin SE, Ardura MI, Wattier RL, Maron G, Grimley M, Paulsen G, Harrison CJ, Freedman JL, Carpenter PA, Englund JA, Munoz FM, Danziger-Isakov L, Spieker AJ, Halasa NB; Pediatric HCT Flu Study.: The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis Oct 2023.
Ghuman A, Devine KJ, Milligan MP, Reilly AR, Freedman JL: Hospitalists in Pediatric Oncology/Stem Cell Transplant: Successes and Opportunities. J Pediatr Hematol Oncol Sept 2023 Notes: doi: 10.1097/MPH.0000000000002747.
Li Y, Vader DT, Oganisian A, Boge CLK, Hayes M, Newman A, Olson T, Freedman J, Elgarten CW, Fisher BT. : Effect of cytomegalovirus infection on post-transplant hospitalization days among children undergoing allogeneic hematopoietic cell transplantation: A marginal structural model approach. Pediatr Transplant Page: e14526, Aug 2023 Notes: doi: 10.1111/petr.14526.
Elgarten CW, Wohlschlaeger A, Levy E, Tadley K, Wang L, Atkinson M, Roberson H, Olson TS, Bunin NJ, Heimall J, Fisher BT, Grupp SJ, Freedman JL: Quality Improvement Initiative to Improve Time and Adherence to Revaccination after Hematopoietic Cell Transplantation: Implementation of a Revaccination Clinic within the HCT program. Transplantation and Cellular Therapy July 2023 Notes: https://doi.org/10.1016/j.jtct.2023.07.020.
Kagami L, Takasaki K, Croy C, Freedman J, Laskin B, Rauch B, Reilly A, Rhodes D, Stundon J, Vardaro J, Batra V : Improving Guideline-Concordant Care for Tumor Lysis Syndrome in Pediatric Oncology Patients (Poster Presentation). American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting, Fort Worth, Texas. May 2023.
Wohlschlaeger Anne, Levy E, Khan R, Heimall J, Fisher Bm Metjian T, Elgarten C, Freedman J: A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplant Recipients. Journal of Pediatric Hematology/Oncology Nursing 40(4): 259-264, Apr 2023 Notes: doi: 10.1177/27527530221147861.
Bahakel H, Spieker A, Stahl A, Rahman H, Amarin J, Carpenter P, Dulek D, Englund J, Schuster J, Hamdan L, Kitko C, Batarseh E, Haddad Z, Stewart L, Coffin S, Ardura M, Wattier R, Maron G, Bocchini C, Moulton E, Grimley M, Paulsen G, Munoz-Rivas F, Freedman J, Danziger-Isakov L. and Halasa N.: Immunogenicity and Safety of Alternative Influenza Vaccination Strategies in Repeated Seasons in Pediatric Hematopoietic-Cell Transplant Recipients (Poster presentation). 4th Symposium of Infectious Diseases in Immunocompromised Hosts, Seattle, Washington. Mar 2023.
Roth E, Reahm D, D'Aprile A, Freedman JL, Grupp S, Wang Y: Infusing Collaboration: Stem Cell Infusion Day Procedure (Poster Presentation). Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, Orlando, Florida. February 2023.